Bakery FSP and GMP Violations Elicit Warning Letter
Following an FDA inspection in Fall of 2023 of a bakery facility that manufactures RTE items, a 483 was issued, but never responded to, so
Following an FDA inspection in Fall of 2023 of a bakery facility that manufactures RTE items, a 483 was issued, but never responded to, so
FDA has issued a warning letter to a farm in Hawaii that grows and packages hearts of palm. The warning letter was a result of
With Listeria monocytogenes having been detected in product samples at a family sprout facility by the state department of agriculture in September 2024, and a
Citing serious violations related to GMPs, hazard analysis, and preventive controls, FDA issued a 483 to a bakery. Having received no written response, the agency
During an FDA inspection at a Vietnamese seafood processor, investigators observed noncompliances with the processor’s HACCP program. Among the serious concerns were that the hazard
During an inspection of a Portuguese seafood processor in Portugal, the FDA identified serious HACCP Violations for which it issued a 483. Among the violations
In a warning letter following the lack of satisfactory response to an inspection’s 483, a Michigan bakery that makes RTE foods was cited for concerns
Although a sprouting operation responded to the citations of the FDA 483 it received following an inspection, the FDA remained concerned about a number of
Following the issuance of a 483 to a baking company, to which it did not respond, FDA issued a warning letter focused on the company’s
Following an inspection of a sprouting and noodle facility in early 2024, a 483 was issued. After FDA reviewed the firm’s response, a warning letter